We’re excited to share a major milestone in OCEANIUM’s mission to deliver science-backed, sustainable seaweed-based ingredients for People Health and Ocean Health.
Our clinical study on OCEAN ACTIVES® H+, conducted in collaboration with EDC BioSynergy, has been published in Microorganisms (MDPI). This is the first-ever clinical trial investigating the prebiotic activity of fucoidan-enriched Saccharina latissima, a bioactive extract from brown seaweed.
The results confirm that OCEAN ACTIVES® H+ enhances gut health, supports a balanced microbiome and improves metabolic functions, reinforcing the promise of seaweed-based solutions in nutritional science.
We’re also proud to have been featured in Nutraceutical Business Review, a recognition of our growing impact in the field of ocean-positive nutrition.
Stay tuned for more exciting developments as we continue advancing the science of seaweed!